RUFY3 promotes the progression of hepatocellular carcinoma through activating NF-κB-mediated epithelial-mesenchymal transition

RUFY3 (RUN and FYVE domain-containing protein 3) has been demonstrated to exhibit carcinogenic effect in multiple malignancies. However, the exact role of RUFY3 in hepatocellular carcinoma (HCC) progression remains elusive. Herein, we aimed to identify the role and the underlying mechanism of RUFY3...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yang, Ni, Weixing, Qin, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457573/
https://www.ncbi.nlm.nih.gov/pubmed/34510031
http://dx.doi.org/10.18632/aging.203444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457573/
https://www.ncbi.nlm.nih.gov/pubmed/34510031
http://dx.doi.org/10.18632/aging.203444

Ejemplares similares